IP single-stain rapid detection is a high-speed flow cytometry technique that uses a single fluorescently labeled antibody to identify and quantify specific cell surface or intracellular markers within one to two hours. This streamlined method combines simple sample preparation with precise quantitative analysis, making it an essential tool for clinical immunophenotyping, cell therapy quality control, and immunology research.
Technical Overview
Immunophenotyping (IP) single-stain rapid detection is a monochromatic flow cytometry assay in which cells are incubated with one fluorochrome-conjugated antibody directed against a single target antigen. After staining, red blood cell lysis, and washing, the sample is acquired on a flow cytometer, where thousands to millions of cells per second pass through a laser beam. The instrument records fluorescence intensity and light-scatter properties for each cell, allowing the laboratory to determine the percentage of antigen-positive cells, calculate absolute counts, and assess marker expression density.
Compared with multi-color panels, single-stain assays eliminate the need for complex fluorescence compensation and elaborate gating strategies. This significantly reduces turnaround time, simplifies data interpretation, and lowers the risk of analytical error, while retaining the high sensitivity and single-cell resolution that flow cytometry provides. Typical turnaround time from sample receipt to report is two to four hours, which is why the method is described as a rapid detection platform.
- Single-antibody staining strategy with minimal compensation requirements
- High sensitivity capable of detecting low-frequency positive populations
- Quantitative output as percentage of positive cells and absolute cell counts
- Rapid workflow with results available within hours of sample collection
- Standardized gating suitable for high-throughput clinical and QC testing
Testing Samples
Peripheral Blood
Peripheral blood collected in EDTA anticoagulant tubes is the most common sample type for single-stain immunophenotyping. Samples should be processed within 24 to 48 hours of collection and stored at 2 to 8 degrees Celsius before staining to preserve antigen integrity and cell viability.
Bone Marrow Aspirates
Bone marrow samples anticoagulated with heparin or EDTA are used for hematological marker screening, blast enumeration, and CD34 progenitor cell assessment. Prompt processing is recommended, typically within 24 hours, and the aspirate should be well mixed to ensure representative sampling.
Body Fluids
Cerebrospinal fluid, pleural effusion, ascites, and synovial fluid can be analyzed after concentration to detect malignant cells or abnormal immune cell populations. These low-cellularity samples benefit from the high sensitivity of flow cytometric detection.
Cell Therapy Products
Final drug products and in-process intermediates from cell therapy manufacturing, such as CAR-T cells, TIL products, and mesenchymal stromal cells, are tested for identity and purity markers. Single-stain assays provide rapid release testing support for potency, identity, and residual impurity evaluation.
Isolated Mononuclear Cells
Peripheral blood mononuclear cells (PBMCs) prepared by density gradient centrifugation or frozen PBMC aliquots are accepted for research-oriented immunophenotyping, viability assessment, and activation marker studies.
Testing Items
Single-stain rapid detection can be configured for any well-characterized cellular marker. Commonly requested targets include:
- T lineage markers: CD3, CD4, CD8, CD5, CD7
- B lineage markers: CD19, CD20, CD22, CD79a
- NK cell markers: CD16, CD56
- Myeloid and monocytic markers: CD13, CD14, CD15, CD33
- Hematopoietic stem and progenitor markers: CD34, CD38, CD45
- Immune checkpoint and activation markers: CD25, CD69, PD-1, HLA-DR
- Histocompatibility antigen: HLA-B27
- Platelet markers: CD41, CD42b, CD61, CD62P
- Apoptosis and viability reagents: Annexin V, 7-AAD, propidium iodide
- Custom single-target staining based on project-specific antibody selection
Testing Methods
The standard single-stain workflow follows a validated five-step procedure designed for speed and reproducibility. Each run includes appropriate controls, such as unstained cells, fluorescence minus one controls where applicable, and calibrator beads for absolute counting.
- Sample reception and verification: sample type, anticoagulant, volume, and collection time are checked against acceptance criteria before testing begins.
- Cell counting and aliquoting: a defined number of cells is dispensed into staining tubes or a 96-well plate to ensure consistent antibody-to-cell ratios.
- Antibody incubation: the single fluorochrome-conjugated antibody is added and incubated for 15 to 30 minutes at room temperature protected from light.
- Red blood cell lysis and washing: a ammonium chloride-based lysing reagent removes erythrocytes in whole blood samples, followed by centrifugation and resuspension in staining buffer.
- Acquisition and analysis: samples are acquired on a calibrated flow cytometer, with gating on the population of interest using forward and side scatter, followed by quantification of the fluorescent positive fraction and, when required, calculation of absolute counts using counting beads.
Data are reported as the percentage of marker-positive cells within the gated population, absolute counts in cells per microliter where applicable, and representative histograms or dot plots. Method validation covers precision, linearity, specificity, and stability of samples under the stated storage conditions.
Applications
Single-stain rapid detection supports a broad range of clinical and research applications where a single, well-defined cellular marker provides the key answer.
- Immune status monitoring: rapid CD4 absolute counting for HIV-infected patients and lymphocyte subset screening for immunodeficiency evaluation.
- Ankylosing spondylitis and autoimmune screening: HLA-B27 detection as a supportive diagnostic marker for seronegative spondyloarthropathies.
- Transplantation support: CD34 stem cell enumeration for peripheral blood stem cell harvest assessment and engraftment monitoring.
- Hematological disease screening: single-marker blast and lineage screening for leukemia and lymphoma workups prior to comprehensive multi-color analysis.
- Cell and gene therapy quality control: identity confirmation, purity determination, residual cell impurity testing, and viability assessment for release testing of cell therapy products.
- Drug development and immunotoxicology: monitoring of drug-induced changes in specific immune cell populations during preclinical and clinical studies.
- Basic and translational research: rapid profiling of surface marker expression, apoptosis analysis with Annexin V single staining, and viability dye assessment in experimental samples.
FAQ
What is the difference between single staining and multi-color staining?
Single staining uses one fluorochrome-conjugated antibody to detect one target, which simplifies compensation and analysis and delivers the fastest turnaround. Multi-color staining combines several antibodies in one tube and is preferred when relationships between multiple markers must be resolved in a single cell population.
How quickly can results be obtained?
Under standard conditions, staining, lysis, acquisition, and analysis are completed within two hours of sample preparation, with final reports typically issued the same day for routine markers.
What are the sample requirements?
Whole blood should be collected in EDTA tubes with a minimum volume of 1 to 2 milliliters and transported at 2 to 8 degrees Celsius, ideally processed within 24 hours. Bone marrow and body fluid requirements vary by marker, and specific acceptance criteria are provided in the sample collection guide.
Can both percentage and absolute counts be reported?
Yes. Percentage of positive cells is provided by default, and absolute counts in cells per microliter are generated using counting beads or a paired hematology analyzer result when requested.
Is the method suitable for low-frequency cell detection?
Single-stain assays can reliably detect minor positive populations at levels typically down to 0.01 to 0.1 percent, depending on the marker, antibody quality, and total event count acquired.